Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review)
International Journal of Molecular Medicine · 22.10.2026 · 58 (6) · 1-16
DOI: 10.3892/ijmm.2026.6024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 22.10.2026. Verfasst von Tao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110847, P.R. China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colorectal Neoplasms, Immunotherapy. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Inflammatory bowel disease‑associated colorectal cancer (IBD‑CRC) arises in the setting of long‑standing chronic intestinal inflammation, in which immune dysregulation cannot be readily attributed to the dominance of a single inhibitory pathway or to global immunosuppression. Persistent inflammatory signaling sustains a state of prolonged immune engagement, yet with constrained effector output, potentially compromising antitumor immune surveillance and limiting the clinical benefit of immunotherapy. The present review synthetises the accumulated knowledge on the long‑term immunological alterations induced by chronic inflammation, including the integration of immune signaling, shifts in activation thresholds, metabolic reprogramming, and functional polarization of immune cells. These changes are discussed in the context of both tumor initiation and tumor maintenance to delineate the immunological evolution of IBD‑CRC. The review further examines the relationship between inflammation‑induced response constraints and the limited efficacy of immune checkpoint inhibitors, and summarizes the mechanistic barriers to immunotherapy in IBD‑CRC. Collectively, these observations suggest that relieving inhibition through a single target may be insufficient to restore effective antitumor immunity. Finally, the potential value of natural plant‑derived interventions characterized by multi‑component, low‑intensity, and long‑term modulation is discussed, particularly with respect to reducing inflammatory burden and improving immune metabolic states, thereby providing a conceptual basis for the development of combination immunotherapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110847, P.R. China.
- Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China.
- School of Nursing, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110847, P.R. China.
- Department of Anorectal Surgery, Second Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110034, P.R. China.
- Department of Anorectal Surgery, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong 518033, P.R. China.
- Administrative Office, Second Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning 110034, P.R. China.
Zitieren
APA
Zhang, T., Ren, Z., Wang, L., Man, R., Wang, L., Wang, J., Cheng, X., Peng, J., & Yu, Y. (2026). Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review). International Journal of Molecular Medicine, 58(6), 1-16. https://doi.org/10.3892/ijmm.2026.6024
Vancouver
Zhang T, Ren Z, Wang L, Man R, Wang L, Wang J, et al. Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review). International Journal of Molecular Medicine. 2026;58(6):1-16. doi:10.3892/ijmm.2026.6024
BibTeX
@article{Zhang2026,
author = {Zhang, Tao and Ren, Zhetan and Wang, Ling and Man, Ru and Wang, Lin and Wang, Jing and Cheng, Xiaozhen and Peng, Jirun and Yu, Yongduo},
title = {Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review)},
journal = {International Journal of Molecular Medicine},
year = {2026},
volume = {58},
number = {6},
pages = {1--16},
doi = {10.3892/ijmm.2026.6024}
}
EUVIMED